10X Genomics Inc TXG

NASDAQ US Materials Life Sciences Tools & Services

$85.71 ▲ +1.90% (+$1.60)

Index member: S&P/TSX Composite

🎢 High Beta

Open $83.76

Prev Close $84.11

Day Range $80.72 – $86.16

52W Range $11.16 – $85.93

Market Cap $9.98B

Beta 2.04

EPS (TTM) $-0.59

📋 Company Profile

Industry	Life Sciences Tools & Services
Sector	Materials
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2019-09-12
Shares Out.	126,960,000
Website	10xgenomics.com/ ↗
Phone	13026587581
Employees	1,178
Revenue	$151.0M
Gross Profit	$112.5M
Net Income	-$17.9M
Free Cash Flow	$121.4M
Total Assets	$1.03B
Total Liabilities	$204.5M
Equity	$825.5M

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

10X Genomics Inc is a publicly traded company under the ticker symbol TXG on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.